Search Icon
Search Icon
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Fetal Development

Pediatricians Recommend More Attention to Pain Management in Premature Infants

The American Academy of Pediatrics (AAP) has released a statement pertaining to the prevention and management of procedural pain in babies.  Pain that newborns experience from routine medical procedures can be significant, especially in premature infants with more intensive health needs.  Research suggests that repeated exposure to pain early in life can create changes in brain development and the stress response systems that can last into childhood.  Premature infants are especially at risk.  The AAP policy statement recommends that every health facility caring for newborns use strategies to minimize the number of painful procedures performed, and routinely monitor and treat pain with greater emphasis on proven non-drug interventions. The policy statement, “Prevention and Management of Procedural Pain in the Neonate: An Update,” appeared in the February 2016 issue of Pediatrics (published online Jan. 25).

Premature infant
Premature infant [Public domain]

As noted in the AAP statement, pain pathways are “active and functional as early as 25 weeks’ gestation” and premature newborns thus may have a generalized or even an exaggerated response to pain.  The repetition of sensory stimuli can be physiologically stressful, particularly in these sensitive preterm infants.  Investigators demonstrated that even simple procedures, such as routine heel puncture for blood draw or tape removal from the skin, can adversely affect future pain perception.  The cortical pain processing that occurs in preterm and term infants is affected by multiple factors involving excitatory and inhibitory feedback mechanisms.

 

The AAP strongly recommends using the neonatal pain assessment tools, which have been proven to be reliable and reproducible.  A number of rating scales factor prematurity into the pain rating system.  In addition to these observation assessments, new technologies to measure neonatal pain are being investigated, including near-infrared spectroscopy, amplitude-integrated electroencephalography, functional MRI, and heart rate variability assessments.  Most of the tools used to measure acute pain in neonates use a combination of physiologic and behavioral signs to gauge pain levels.  Published studies using current rating scales included infants from 23 weeks prematurity through 2 months of age.  These studies support the existence of pain in infants midway through gestation and beyond.

 

The AAP recommends routine pain management during procedures such as circumcision, chest drain insertion and removal, and nonemergency intubations.  More studies of the dosing and long-term effects of analgesics in the newborn period are needed. As the AAP states, there is a critical need to achieve adequate pain control in newborns, “both as an ethical duty and because painful experiences in the NICU can have long-term adverse effects.”  Preventing or minimizing pain in neonates should be the goal of pediatricians and other health care professionals who care for babies.

 

Colleen Malloy, M.D. is Associate Professor in Clinical Pediatrics/Neonatology, Ann & Robert H. Lurie Children’s Hospital of Chicago and Northwestern University Feinberg School of Medicine.

 

Latest Posts

October 6, 2026 A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification. A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Ultrasound image showing the side profile of a human baby Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined. Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

You Might Also Be Interested In

An anatomical model of a fetus in utero used for prenatal education, shown in a cross-section view on a display stand.

Fact Sheet: Fetal Development Education in the United States

September 15, 2026
A woman smiles and holds up an ultrasound image of an unborn baby, seated at a desk with a computer, photos, and a drink bottle in the background.

Science Is Making the Humanity of Unborn Babies Harder to Ignore

May 24, 2026
A developing human baby is shown on the right against a red background. On the left, a “New Updates” label, geometric logo, and a vertical measurement scale appear, highlighting Unborn Baby Development in a modern, medical-themed design.

Charlotte Lozier Institute Launches Updated Unborn Baby Development Guide, New Pregnancy Calculator

charlotte-lozier-institute Charlotte Lozier Institute
May 7, 2026

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image